A Study of Mirikizumab in Healthy Chinese Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The main purpose of this study is to evaluate the safety of the study drug known as mirikizumab. The study will investigate how the body processes the study drug. It will last up to about 4 months for each participant.
Epistemonikos ID: 735c1d017fa121d9b3e4e8f2c7fc0530f3414c95
First added on: May 06, 2024